MicroPort Scientific Corp
The company traces its origins back to 1998 to a small office in the ZJ Hi-Tech Park, of Shanghai and a group of people who shared the belief that medical technology advances could improve people's well-being not just in China but globally. Over the past two decades, MicroPort® has devoted itself to this mission advancing technological innovations to develop the best, most affordable medical treatments around the globe.
Years of innovation and growth have helped it become a premier medical solutions provider in 10 major disciplines, including interventional cardiology, orthopedics, interventional radiology, electrophysiology, cardiac rhythm management, diabetes and endocrine management, and surgical management. And it has more than 165 products approved for use in over 5,000 hospitals worldwide, so MicroPort® is contributing to a better world through life-saving medical therapies and quality care devices being used for treatments every 18 seconds.
With its large global reach in R&D and manufacturing -- in the cities of Shanghai, Beijing, and Shenzhen, and Jiangsu and Zhejiang provinces, in China, and in Memphis, TN in the United States -- it has a sharp focus on technological innovation and more than 1,600 patents, as well as a a global workforce of at least 3,000, MicroPort’'s vision is of a patient-oriented company with a leading role in the future of minimally invasive healthcare and other advanced technologies.